Stay updated on Pyrotinib vs Docetaxel in HER2 NSCLC Clinical Trial

Sign up to get notified when there's something new on the Pyrotinib vs Docetaxel in HER2 NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pyrotinib vs Docetaxel in HER2 NSCLC Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    No new additions were noted, but a significant section of content related to downloading data formats and selecting study fields has been removed.
    Difference
    13%
    Check dated 2024-11-23T04:37:26.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    Several key government health and information websites have been removed from the monitored list.
    Difference
    0.7%
    Check dated 2024-11-15T23:47:48.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Summary
    The website has been updated to version 2.12.2, adding several new resource links and enhancing the data download options, while the previous version 2.12.1 has been removed.
    Difference
    16%
    Check dated 2024-11-08T18:25:09.000Z thumbnail image
  5. Check
    33 days ago
    Change Detected
    Summary
    The website has been updated from version 2.12.0 to 2.12.1.
    Difference
    0.3%
    Check dated 2024-11-01T10:50:50.000Z thumbnail image
  6. Check
    41 days ago
    Change Detected
    Summary
    The website has been updated from version 2.11.2 to 2.12.0, indicating a new release with potential enhancements or features.
    Difference
    0.6%
    Check dated 2024-10-25T00:46:32.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    The website has been updated from version 2.11.0 to 2.11.2, indicating new features or improvements.
    Difference
    0.3%
    Check dated 2024-10-03T04:55:44.000Z thumbnail image

Stay in the know with updates to Pyrotinib vs Docetaxel in HER2 NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pyrotinib vs Docetaxel in HER2 NSCLC Clinical Trial page.